Metabolism and excretion of ropivacaine in humans

Drug Metabolism and Disposition

Volumn 24, Issue 9, 1996, Pages 962-968

  Halldin, M M ^a   Bredberg, E ^a   Angelin, B ^b   Arvidsson, T ^a   Askemark, Y ^a   Elofsson, S ^a   Widman, M ^a,c  

^a ASTRAZENECA R AND D   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ROPIVACAINE;

ADULT; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG INFUSION; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG URINE LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AMIDES; ANESTHETICS, LOCAL; AREA UNDER CURVE; BIOTRANSFORMATION; CARBON RADIOISOTOPES; FECES; HALF-LIFE; HUMANS; MALE;

EID: 0029809853     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. B. Åkerman, I.-B. Hellberg, and C. Trossvik: Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA103). Acta Anaesthesiol. Scand. 32, 571-578 (1988).
2. A. Lee, D. Fagan, M. Lamont, G. T. Tucker, M. Halldin, and D. B. Scott: Disposition kinetics of ropivacaine in humans. Anesth. Analg. 69, 736-738 (1989).
3. B. M. Emanuelsson, J. Persson, C. Alm, Å. Magnusson, and L. G. Gustafsson: Pharmacokinetics of ropivacaine in volunteers after three intravenous doses. Clin. Pharmacol. Ther. 55, 123 (1994).
4. J. A. Katz, P. O. Bridenbaugh, D. C. Knarr, S. H. Helton, and D. D. Denson: Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans. Anesth. Analg. 70, 16-21 (1990).
5. D. B. Scott, A. Lee, D. Fagan, G. M. R. Bowler, P. Bloomfield, and R. Lundh: Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth. Analg. 69, 563-569 (1989).
6. M. Björk, K.-J. Petterson, and G. Osterlöf: Capillary gas chromatographic method for the simultaneous determination of local anaesthetics in plasma samples. J. Chromatogr. 553, 229-234 (1990).
7. M. Rowland and T. Tozer, eds.: "Clinical Pharmacokinetics: Concepts and Applications." Lea & Fabriger, Philadelphia, 1989.
8. A. C. Guyton: "Textbook of Medical Physiology," ed. 7, p. 340. W. B. Saunders, Philadelphia, 1986.
9. G. Ekström and U.-B. Gunnarsson: Ropivacaine, a new amide-type local anesthetic agent, is metabolized bv cytochromes P450 1A and 3A in human liver microsomes. Drug Metab Dispos. 14, 953-961 (1996).
10. T. Arvidsson, H. Forsmo Bruce, and M. M. Halldin: Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column. Chirality 7, 272-277 (1994).
11. G. T. Tucker and L. E. Mather: Properties, absorption and disposition of local anesthetic agents. In "Neural Blockade in Clinical Anesthesia and Management of Pain" (M. M. Cousins and P. O. Bridenbaugh, eds.), pp. 47-100. J. B. Lippincott Co., Philadelphia, 1988.
12. J. Thomas and P. Meffin: Aromatic hydroxylation of lidocaine and mepivacaine in rats and humans. J. Med. Chem. 15, 1046-1049 (1972).
13. R. Dennhardt and H. Konder: Metabolite von Bupivacain beim Menschen. Reg. Anaesth. 3, 25-26 (1980).
14. K. Pihlajamäki, J. Kanto, R. Lindberg, M. Karanko, and P. Kiilholma: Extradural administration of bupivacaine: pharmacokinetics and metabolism in pregnant and non-pregnant women. Br. J. Anaesth. 64, 556-562 (1990).